AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Medtronic to participate in investor conferences in September.
ByAinvest
Friday, Aug 29, 2025 11:32 am ET1min read
Medtronic plc, a global leader in healthcare technology, announced its participation in several investor conferences in September 2025. Geoff Martha, CEO, and Thierry Piéton, CFO, will speak at the 2025 Wells Fargo Healthcare Conference and Morgan Stanley 23rd Annual Global Healthcare Conference. Thierry Piéton will also speak at the 2025 Deutsche Bank Healthcare Summit, and Greg Smith will speak at the BofA Global Research Global Healthcare Conference 2025.
Medtronic plc, a global leader in healthcare technology, has announced its participation in several investor conferences in September 2025. The company will be represented by key executives at the 2025 Wells Fargo Healthcare Conference, Morgan Stanley 23rd Annual Global Healthcare Conference, 2025 Deutsche Bank Healthcare Summit, and BofA Global Research Global Healthcare Conference 2025.Conference Details:
- 2025 Wells Fargo Healthcare Conference:
- Date: Thursday, September 4, 2025
- Time: 8:00 a.m. EDT (7:00 a.m. CDT)
- Speakers: Geoff Martha, chairman and CEO, and Thierry Piéton, executive vice president and chief financial officer
- Morgan Stanley 23rd Annual Global Healthcare Conference:
- Date: Monday, September 8, 2025
- Time: 4:50 p.m. EDT (3:50 p.m. CDT)
- Speaker: Thierry Piéton, executive vice president and chief financial officer
- 2025 Deutsche Bank Healthcare Summit:
- Date: Wednesday, September 10, 2025
- Time: 12:00 p.m. EDT (11:00 a.m. CDT)
- Speaker: Greg Smith, executive vice president, enterprise operations
- BofA Global Research Global Healthcare Conference 2025:
- Date: Wednesday, September 24, 2025
- Time: 2:10 p.m. BST (8:10 a.m. CDT)
- Speaker: Thierry Piéton, executive vice president and chief financial officer
Live Webcast and Archive Availability:
A live webcast for each session will be available on the date and time of each conference. An archive session will be available on the same webpage later in the day. Interested investors can access these sessions by clicking on the "Investors Events" link at: [http://investorrelations.medtronic.com](http://investorrelations.medtronic.com).
About Medtronic:
Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company. The company's mission is to alleviate pain, restore health, and extend life. It employs over 95,000 people across more than 150 countries and delivers innovative technologies that treat 70 health conditions, including cardiac devices, surgical robotics, insulin pumps, and patient monitoring systems [1].
References:
[1] https://finance.yahoo.com/news/medtronic-executives-speak-upcoming-investor-152100455.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet